Literature DB >> 23927605

Developmental hemostasis: age-specific differences in the levels of hemostatic proteins.

C Attard1, T van der Straaten, V Karlaftis, P Monagle, V Ignjatovic.   

Abstract

INTRODUCTION: Developmental hemostasis recognizes the physiologic differences between the hemostatic system of neonates and children and that of adults. As compared with the knowledge of hemostatic system physiology in adults, our understanding in neonates and children remains inadequate. Routine clinical coagulation testing most commonly measures functional parameters of the hemostatic system. Very few studies have measured age-specific levels of hemostatic proteins. An understanding of the normal fluctuations in the levels of hemostatic proteins is vital in the prevention, diagnosis and treatment of hemostatic problems during infancy and childhood. This study was designed as the first comprehensive study of the age-specific changes in the levels of important hemostatic proteins in healthy neonates, children, and adults.
METHODS: Plasma samples were obtained from 120 healthy individuals from the following age groups: neonates (day 1 and day 3), 28 days to 1 year, 1-5 years, 6-10 years, 11-16 years, and adults. Factor II, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, plasminogen, protein C and total and free protein S were quantified with commercially available ELISA kits.
RESULTS: The levels of 10 proteins were significantly different between neonates and adults, and these differences persisted throughout childhood for most of these proteins.
CONCLUSION: The results of this study confirm that the levels of the majority of coagulation proteins vary significantly with age. Future studies should investigate how hemostatic protein level relates to functional changes with age.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood coagulation factors; hemostasis; neonatal screening; pediatrics; reference ranges

Mesh:

Substances:

Year:  2013        PMID: 23927605     DOI: 10.1111/jth.12372

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

1.  Decreased numbers of dense granules in fetal and neonatal platelets.

Authors:  Denisa Urban; Fred G Pluthero; Hilary Christensen; Shoma Baidya; Margaret L Rand; Animitra Das; Prakeshkumar S Shah; David Chitayat; Victor S Blanchette; Walter H A Kahr
Journal:  Haematologica       Date:  2016-11-03       Impact factor: 9.941

2.  Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults.

Authors:  Stefan Bjelosevic; Dana Pascovici; Hui Ping; Vasiliki Karlaftis; Thiri Zaw; Xiaomin Song; Mark P Molloy; Paul Monagle; Vera Ignjatovic
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

3.  Coagulopathy Characterized by Rotational Thromboelastometry in a Porcine Pediatric ECMO Model.

Authors:  Christopher R Reed; Desiree Bonadonna; Jeffrey Everitt; Victoria Robinson; James Otto; Elisabeth T Tracy
Journal:  J Extra Corpor Technol       Date:  2020-09

Review 4.  Venous thromboembolism in critically ill children.

Authors:  Lee A Polikoff; E Vincent S Faustino
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

5.  Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Authors:  Amanda P Waller; Jonathan P Troost; Samir V Parikh; Katelyn J Wolfgang; Brad H Rovin; Marvin T Nieman; William E Smoyer; Matthias Kretzler; Bryce A Kerlin
Journal:  Thromb Res       Date:  2021-02-16       Impact factor: 3.944

6.  Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts.

Authors:  Conor McCafferty; Suelyn Van Den Helm; Natasha Letunica; Chantal Attard; Vasiliki Karlaftis; Tengyi Cai; Slavica Praporski; Ella Swaney; David Burgner; Melanie Neeland; Kate Dohle; Nigel W Crawford; Luisa Clucas; Shidan Tosif; Vera Ignjatovic; Paul Monagle
Journal:  Br J Haematol       Date:  2021-06-07       Impact factor: 8.615

Review 7.  Transfusion therapy in paediatric trauma patients: a review of the literature.

Authors:  Kristin Brønnum Nystrup; Jakob Stensballe; Morten Bøttger; Pär I Johansson; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-02-15       Impact factor: 2.953

8.  Determination of Age-Dependent Reference Ranges for Coagulation Tests Performed Using Destiny Plus.

Authors:  Fatma Demet Arslan; Muhittin Serdar; Elif Merve Ari; Mustafa Onur Oztan; Sureyya Hikmet Kozcu; Huseyin Tarhan; Ozgur Cakmak; Merve Zeytinli; Hamit Yasar Ellidag
Journal:  Iran J Pediatr       Date:  2016-04-30       Impact factor: 0.364

Review 9.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

10.  Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design.

Authors:  Matteo Luciani; Manuela Albisetti; Branislav Biss; Lisa Bomgaars; Martina Brueckmann; Elizabeth Chalmers; Savion Gropper; Jacqueline M L Halton; Ruth Harper; Fenglei Huang; Ivan Manastirski; Lesley G Mitchell; Igor Tartakovsky; Bushi Wang; Leonardo R Brandão
Journal:  Res Pract Thromb Haemost       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.